Hot Features
プレミアム
LillyEli & Co (1LLY)
BIT
ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-06 | Lilly Endowment Inc.法人 | -15.83k | 15.75M | 売り | 995.23 - 996.18 | 91.88M | -0.02% |
| 2026-02-19 | Mr. Eric DozierExec. VP & CPO | -481.00 | 0.00 | Other Disposition | - | 14.84k | -3.14% |
| 2026-02-16 | Mr. Donald A. ZakrowskiSenior VP of Finance & CAO | 102.45 | 0.00 | Derivative Exercise and Retained Stock | - | 5.25k | 1.99% |
| 2026-02-16 | Mr. Donald A. ZakrowskiSenior VP of Finance & CAO | -81.55 | 84.82k | Derivative Exercise and Sale | 1.04k | 5.25k | - |
| 2026-02-16 | Mr. Lucas E. MontarceExec. VP & CFO | 208.27 | 0.00 | Derivative Exercise and Retained Stock | - | 16.26k | 1.30% |
| 2026-02-16 | Mr. Lucas E. MontarceExec. VP & CFO | -159.73 | 166.12k | Derivative Exercise and Sale | 1.04k | 16.26k | - |
| 2026-02-16 | Mr. Kenneth L. CusterExec. VP & President of Lilly Cardiometabolic Health | 115.69 | 0.00 | Derivative Exercise and Retained Stock | - | 10.14k | 1.15% |
| 2026-02-16 | Mr. Kenneth L. CusterExec. VP & President of Lilly Cardiometabolic Health | -91.31 | 94.96k | Derivative Exercise and Sale | 1.04k | 10.14k | - |
| 2026-02-16 | Ms. Adrienne BrownExec. VP & President of Lilly Immunology | 221.03 | 0.00 | Derivative Exercise and Retained Stock | - | 5.14k | 4.49% |
| 2026-02-16 | Ms. Adrienne BrownExec. VP & President of Lilly Immunology | -169.97 | 176.76k | Derivative Exercise and Sale | 1.04k | 5.14k | - |
| 2026-02-01 | Mr. Ilya YuffaExec. VP and President of Lilly USA & Global Customer Capabilities | 1.88k | 0.00 | Derivative Exercise and Retained Stock | - | 28.14k | 7.17% |
| 2026-02-01 | Mr. Ilya YuffaExec. VP and President of Lilly USA & Global Customer Capabilities | -1.51k | 1.57M | Derivative Exercise and Sale | 1.04k | 28.14k | - |
| 2026-02-01 | Dr. Daniel M. SkovronskyChief Scientific & Product Officer and President of Lilly Research Laboratories | 7.04k | 0.00 | Derivative Exercise and Retained Stock | - | 220.14k | 3.30% |
| 2026-02-01 | Dr. Daniel M. SkovronskyChief Scientific & Product Officer and President of Lilly Research Laboratories | -5.64k | 5.85M | Derivative Exercise and Sale | 1.04k | 220.14k | - |
| 2026-02-01 | Mr. Jacob S. Van NaardenExec. VP, President of Lilly Oncology & Head of Corporate Business Development | 2.20k | 0.00 | Derivative Exercise and Retained Stock | - | 31.41k | 7.53% |
| 2026-02-01 | Mr. Jacob S. Van NaardenExec. VP, President of Lilly Oncology & Head of Corporate Business Development | -1.91k | 1.98M | Derivative Exercise and Sale | 1.04k | 31.41k | - |
| 2026-02-01 | Mr. Diogo RauExec. VP and Chief Information & Digital Officer | 2.08k | 0.00 | Derivative Exercise and Retained Stock | - | 21.80k | 10.54% |
| 2026-02-01 | Mr. Diogo RauExec. VP and Chief Information & Digital Officer | -1.67k | 1.74M | Derivative Exercise and Sale | 1.04k | 21.80k | - |
| 2026-02-01 | Mr. David A. RicksChairman & CEO | 17.64k | 0.00 | Derivative Exercise and Retained Stock | - | 751.81k | 2.40% |
| 2026-02-01 | Mr. David A. RicksChairman & CEO | -14.30k | 14.83M | Derivative Exercise and Sale | 1.04k | 751.81k | - |
| 2026-02-01 | Mr. Patrik JonssonExec. VP & President of Lilly International | 2.18k | 0.00 | Derivative Exercise and Retained Stock | - | 56.44k | 4.01% |
| 2026-02-01 | Mr. Patrik JonssonExec. VP & President of Lilly International | -1.75k | 1.82M | Derivative Exercise and Sale | 1.04k | 56.44k | - |
| 2026-02-01 | Mr. Edgardo HernandezExec. VP & President of Manufacturing Operations | 1.98k | 0.00 | Derivative Exercise and Retained Stock | - | 42.58k | 4.88% |
| 2026-02-01 | Mr. Edgardo HernandezExec. VP & President of Manufacturing Operations | -1.59k | 1.65M | Derivative Exercise and Sale | 1.04k | 42.58k | - |
| 2026-02-01 | Ms. Anat HakimExec. VP, General Counsel & Secretary | 3.75k | 0.00 | Derivative Exercise and Retained Stock | - | 47.28k | 8.61% |
| 2026-02-01 | Ms. Anat HakimExec. VP, General Counsel & Secretary | -2.95k | 3.06M | Derivative Exercise and Sale | 1.04k | 47.28k | - |
| 2026-02-01 | Mr. Eric DozierExec. VP & CPO | 1.59k | 0.00 | Derivative Exercise and Retained Stock | - | 11.80k | 15.51% |
| 2026-02-01 | Mr. Eric DozierExec. VP & CPO | -1.27k | 1.32M | Derivative Exercise and Sale | 1.04k | 11.80k | - |
| 2026-01-07 | Lilly Endowment Inc.法人 | -292.15k | 322.38M | 売り | 1.09k - 1.12k | 91.90M | -0.32% |
| 2026-01-05 | Lilly Endowment Inc.法人 | -1.39k | 1.51M | 売り | 1.09k | 92.19M | -0.00% |
| 2025-12-29 | Lilly Endowment Inc.法人 | -3.59k | 3.90M | 売り | 1.09k | 92.19M | -0.00% |
| 2025-12-23 | Lilly Endowment Inc.法人 | -2.87k | 3.11M | 売り | 1.09k | 92.19M | -0.00% |
| 2025-11-25 | Lilly Endowment Inc.法人 | -162.69k | 178.42M | 売り | 1.07k - 1.11k | 92.20M | -0.18% |
| 2025-11-24 | Lilly Endowment Inc.法人 | -142.31k | 152.06M | 売り | 1.07k | 92.36M | -0.15% |
| 2025-11-21 | Lilly Endowment Inc.法人 | -105.33k | 111.50M | 売り | 1.05k - 1.07k | 92.50M | -0.11% |
| 2025-11-20 | Lilly Endowment Inc.法人 | -37.15k | 39.07M | 売り | 1.05k - 1.06k | 92.61M | -0.04% |
| 2025-11-19 | Lilly Endowment Inc.法人 | -167.53k | 176.10M | 売り | 1.05k - 1.06k | 92.64M | -0.18% |
| 2025-11-18 | Lilly Endowment Inc.法人 | -60.21k | 62.31M | 売り | 1.03k - 1.04k | 92.81M | -0.06% |
| 2025-11-17 | Lilly Endowment Inc.法人 | -9.89k | 10.19M | 売り | 1.03k | 92.87M | -0.01% |
| 2025-11-14 | Lilly Endowment Inc.法人 | -178.30k | 183.80M | 売り | 1.03k | 92.88M | -0.19% |
| 2025-11-13 | Lilly Endowment Inc.法人 | -46.61k | 48.02M | 売り | 1.03k | 93.06M | -0.05% |
| 2025-11-13 | Mr. Donald A. ZakrowskiSenior VP of Finance & CAO | -1,000.00 | 1.01M | Automatic Disposition | 1.01k | 4.57k | -17.96% |
| 2025-11-12 | Lilly Endowment Inc.法人 | -305.00k | 308.41M | 売り | 1.00k - 1.02k | 93.11M | -0.33% |
| 2025-11-10 | Lilly Endowment Inc.法人 | -300.00k | 295.75M | 売り | 972.17 - 999.09 | 93.41M | -0.32% |
| 2025-11-10 | Mr. David A. RicksChairman & CEO | -24.75k | 0.00 | Other Disposition | - | 734.17k | -3.26% |
| 2025-11-10 | Dr. Daniel M. SkovronskyChief Scientific & Product Officer and President of Lilly Research Laboratories | -179.00 | 0.00 | Other Disposition | - | 213.10k | -0.08% |
| 2025-11-05 | Lilly Endowment Inc.法人 | -219.47k | 205.57M | 売り | 911.01 - 954.95 | 93.71M | -0.23% |
| 2025-11-04 | Lilly Endowment Inc.法人 | -526.00 | 479.04k | 売り | 910.72 | 93.93M | -0.00% |
| 2025-11-03 | Lilly Endowment Inc.法人 | -300.00k | 266.65M | 売り | 877.40 - 900.79 | 93.93M | -0.32% |
| 2025-10-31 | Lilly Endowment Inc.法人 | -301.34k | 260.17M | 売り | 862.63 - 869.47 | 94.23M | -0.32% |
| 2025-10-10 | Lilly Endowment Inc.法人 | -3.66k | 3.16M | 売り | 862.34 - 863.37 | 94.53M | -0.00% |
| 2025-10-09 | Lilly Endowment Inc.法人 | -10.60k | 9.04M | 売り | 848.63 - 857.26 | 94.54M | -0.01% |
| 2025-10-08 | Lilly Endowment Inc.法人 | -101.42k | 86.23M | 売り | 848.46 - 856.00 | 94.55M | -0.11% |
| 2025-10-07 | Lilly Endowment Inc.法人 | -26.80k | 22.72M | 売り | 848.01 | 94.65M | -0.03% |
| 2025-10-06 | Lilly Endowment Inc.法人 | -161.18k | 137.04M | 売り | 848.30 - 855.71 | 94.68M | -0.17% |
| 2025-10-03 | Lilly Endowment Inc.法人 | -192.40k | 161.22M | 売り | 821.42 - 847.60 | 94.84M | -0.20% |
| 2025-10-02 | Lilly Endowment Inc.法人 | -112.60k | 92.50M | 売り | 821.09 - 833.92 | 95.03M | -0.12% |
| 2025-10-01 | Lilly Endowment Inc.法人 | -351.02k | 284.65M | 売り | 765.75 - 833.15 | 95.14M | -0.37% |
| 2025-09-30 | Lilly Endowment Inc.法人 | -113.69k | 86.79M | 売り | 763.10 - 766.12 | 95.49M | -0.12% |
| 2025-09-19 | Lilly Endowment Inc.法人 | -23.67k | 18.06M | 売り | 763.05 - 764.47 | 95.61M | -0.02% |
| 2025-09-18 | Lilly Endowment Inc.法人 | -106.63k | 81.53M | 売り | 763.29 - 767.07 | 95.63M | -0.11% |
| 2025-09-05 | Mr. Edgardo HernandezExec. VP & President of Manufacturing Operations | -17.00 | 0.00 | Other Disposition | - | 40.60k | -0.04% |
| 2025-08-27 | Mr. Kenneth L. CusterExec. VP & President of Lilly Cardiometabolic Health | 612.94 | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 2.17k | 39.29% |
| 2025-08-28 | Mr. Donald A. ZakrowskiSenior VP of Finance & CAO | -1,000.00 | 734.93k | Automatic Disposition | 734.93 | 5.57k | -15.23% |
| 2025-08-15 | Mr. Lucas E. MontarceExec. VP & CFO | 715.00 | 494.63k | 買い | 691.79 | 14.69k | 5.12% |
| 2025-08-13 | Mr. Ralph AlvarezIndependent Director | 758.00 | 500.47k | 買い | 660.25 | 758.00 | - |
| 2025-08-13 | Mr. Jacob S. Van NaardenExec. VP, President of Lilly Oncology & Head of Corporate Business Development | 1,000.00 | 647.36k | 買い | 647.36 | 29.21k | 3.55% |
| 2025-08-12 | Mr. David A. RicksChairman & CEO | 1.63k | 1.05M | 買い | 644.77 | 758.91k | 0.22% |
| 2025-08-12 | Dr. Daniel M. SkovronskyChief Scientific & Product Officer and President of Lilly Research Laboratories | 1,000.00 | 634.41k | 買い | 634.41 | 213.28k | 0.47% |
| 2025-08-12 | Ms. Gabrielle SulzbergerIndependent Director | 117.00 | 75.02k | 買い | 641.18 | 2.70k | 4.52% |
| 2025-08-12 | Mr. Jon Erik FyrwaldIndependent Director | 1.57k | 1.01M | 買い | 642.00 - 642.59 | 1.68k | 1,326.27% |
| 2025-08-11 | Mr. Ilya YuffaExec. VP and President of Lilly USA & Global Customer Capabilities | -1.25k | 783.76k | Automatic Disposition | 627.01 | 26.26k | -4.54% |
| 2025-08-08 | Mr. Jamere JacksonIndependent Director | 200.00 | 127.91k | 買い | 639.56 | 200.00 | - |
| 2025-08-01 | Ms. Melissa S. SeymourExec. VP of Global Quality | 525.08 | 0.00 | Derivative Exercise and Retained Stock | - | 525.00 | - |
| 2025-08-01 | Ms. Melissa S. SeymourExec. VP of Global Quality | -426.92 | 315.95k | Derivative Exercise and Sale | 740.07 | 525.00 | - |
| 2025-07-24 | Lilly Endowment Inc.法人 | -280.00k | 225.42M | 売り | 803.48 - 808.34 | 95.74M | -0.29% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
